Development of new bexarotene-loaded mesoporous silica systems for topical pharmaceutical formulations

The present study reports the first time use of MCM-41 mesoporous silica as highly efficient carrier for bexarotene - an antineoplastic agent specific for cutaneous T-cell lymphoma treatment. Bexarotene is highly toxic and poor-water soluble, having low bioavailability in the conventional pharmaceut...

Full description

Bibliographic Details
Main Authors: Aurelia Vasile, Maria Ignat, Mirela Fernanda Zaltariov, Liviu Sacarescu, Iulian Stoleriu, Dan Draganescu, Mihai Dumitras, Lacramioara Ochiuz
Format: Article
Language:English
Published: Slovenian Chemical Society 2018-03-01
Series:Acta Chimica Slovenica
Subjects:
Online Access:https://journals.matheo.si/index.php/ACSi/article/view/3641
id doaj-0d0341f749e24b47b4c6ecfdce8117bf
record_format Article
spelling doaj-0d0341f749e24b47b4c6ecfdce8117bf2020-11-25T00:50:00ZengSlovenian Chemical SocietyActa Chimica Slovenica1318-02071580-31552018-03-016519710710.17344/acsi.2017.3641545Development of new bexarotene-loaded mesoporous silica systems for topical pharmaceutical formulationsAurelia Vasile0Maria Ignat1Mirela Fernanda Zaltariov2Liviu Sacarescu3Iulian Stoleriu4Dan Draganescu5Mihai Dumitras6Lacramioara Ochiuz7"Alexandru Ioan Cuza" University"Alexandru Ioan Cuza" University / Institute of Macromolecular Chemistry "Petru Poni"Institute of Macromolecular Chemistry "Petru Poni"Institute of Macromolecular Chemistry "Petru Poni""Alexandru Ioan Cuza" UniversityAPIS Laboratories LTD"Alexandru Ioan Cuza" University“Gr.T. Popa” University of Medicine and PharmacyThe present study reports the first time use of MCM-41 mesoporous silica as highly efficient carrier for bexarotene - an antineoplastic agent specific for cutaneous T-cell lymphoma treatment. Bexarotene is highly toxic and poor-water soluble, having low bioavailability in the conventional pharmaceutical forms. Comparative uptake of bexarotene on amino-functionalized silica host at various functionalization degrees is discussed in details taking into account all structural features, of matrix as well as properties of the drug molecules. The obtained results proved a successful bexarotene loading on amino-functionalized MCM-41 silica. The bexarotene molecules are adsorbed on the active centers in non-crystalline state proving the major role of the silica amino-functionalization for the drug solubility and bioavailability enhancing. In vitro dissolution tests showed a prolonged release of bexarotene during 12 h, reaching 50% release of loaded active molecules. The prolonged release has been demonstrated to be a result of the presence of aminopropyl groups on the silica pore walls.https://journals.matheo.si/index.php/ACSi/article/view/3641aminofunctionalized mesoporous silicacarrier bexarotenerelease
collection DOAJ
language English
format Article
sources DOAJ
author Aurelia Vasile
Maria Ignat
Mirela Fernanda Zaltariov
Liviu Sacarescu
Iulian Stoleriu
Dan Draganescu
Mihai Dumitras
Lacramioara Ochiuz
spellingShingle Aurelia Vasile
Maria Ignat
Mirela Fernanda Zaltariov
Liviu Sacarescu
Iulian Stoleriu
Dan Draganescu
Mihai Dumitras
Lacramioara Ochiuz
Development of new bexarotene-loaded mesoporous silica systems for topical pharmaceutical formulations
Acta Chimica Slovenica
aminofunctionalized mesoporous silica
carrier bexarotene
release
author_facet Aurelia Vasile
Maria Ignat
Mirela Fernanda Zaltariov
Liviu Sacarescu
Iulian Stoleriu
Dan Draganescu
Mihai Dumitras
Lacramioara Ochiuz
author_sort Aurelia Vasile
title Development of new bexarotene-loaded mesoporous silica systems for topical pharmaceutical formulations
title_short Development of new bexarotene-loaded mesoporous silica systems for topical pharmaceutical formulations
title_full Development of new bexarotene-loaded mesoporous silica systems for topical pharmaceutical formulations
title_fullStr Development of new bexarotene-loaded mesoporous silica systems for topical pharmaceutical formulations
title_full_unstemmed Development of new bexarotene-loaded mesoporous silica systems for topical pharmaceutical formulations
title_sort development of new bexarotene-loaded mesoporous silica systems for topical pharmaceutical formulations
publisher Slovenian Chemical Society
series Acta Chimica Slovenica
issn 1318-0207
1580-3155
publishDate 2018-03-01
description The present study reports the first time use of MCM-41 mesoporous silica as highly efficient carrier for bexarotene - an antineoplastic agent specific for cutaneous T-cell lymphoma treatment. Bexarotene is highly toxic and poor-water soluble, having low bioavailability in the conventional pharmaceutical forms. Comparative uptake of bexarotene on amino-functionalized silica host at various functionalization degrees is discussed in details taking into account all structural features, of matrix as well as properties of the drug molecules. The obtained results proved a successful bexarotene loading on amino-functionalized MCM-41 silica. The bexarotene molecules are adsorbed on the active centers in non-crystalline state proving the major role of the silica amino-functionalization for the drug solubility and bioavailability enhancing. In vitro dissolution tests showed a prolonged release of bexarotene during 12 h, reaching 50% release of loaded active molecules. The prolonged release has been demonstrated to be a result of the presence of aminopropyl groups on the silica pore walls.
topic aminofunctionalized mesoporous silica
carrier bexarotene
release
url https://journals.matheo.si/index.php/ACSi/article/view/3641
work_keys_str_mv AT aureliavasile developmentofnewbexaroteneloadedmesoporoussilicasystemsfortopicalpharmaceuticalformulations
AT mariaignat developmentofnewbexaroteneloadedmesoporoussilicasystemsfortopicalpharmaceuticalformulations
AT mirelafernandazaltariov developmentofnewbexaroteneloadedmesoporoussilicasystemsfortopicalpharmaceuticalformulations
AT liviusacarescu developmentofnewbexaroteneloadedmesoporoussilicasystemsfortopicalpharmaceuticalformulations
AT iulianstoleriu developmentofnewbexaroteneloadedmesoporoussilicasystemsfortopicalpharmaceuticalformulations
AT dandraganescu developmentofnewbexaroteneloadedmesoporoussilicasystemsfortopicalpharmaceuticalformulations
AT mihaidumitras developmentofnewbexaroteneloadedmesoporoussilicasystemsfortopicalpharmaceuticalformulations
AT lacramioaraochiuz developmentofnewbexaroteneloadedmesoporoussilicasystemsfortopicalpharmaceuticalformulations
_version_ 1725249848430559232